HER2 codon 655 polymorphism and breast cancer risk: A meta-analysis

Breast Cancer Research and Treatment

Volumn 114, Issue 2, 2009, Pages 371-376

  Tao, Weiyang ^a   Wang, Chunyang ^b   Han, Ruifa ^b   Jiang, Hongchi ^a  

^a THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Breast neoplasms; HER2; Meta analysis; Molecular epidemiology; Single nucleotide polymorphism

Indexed keywords

ARTICLE; ASIAN; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CAUCASIAN; CODON; FAMILY HISTORY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC SUSCEPTIBILITY; HUMAN; ONCOGENE NEU; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; CODON; FEMALE; GENES, ERBB-2; GENOTYPE; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 59449096528     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-008-0010-9     Document Type: Article

References (31)

1. S Tommasi V Fedele R Lacalamita 2004 Molecular and functional characteristics of erbB2 in normal and cancer breast cells Cancer Lett 209 215 222
2. T Cooke J Reeves A Lanigan 2001 HER2 as a prognostic and predictive marker for breast cancer Ann Oncol 12 S23 S28
3. JS Ross JA Fletcher GP Linette 2003 The Her-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy Oncologist 8 307 325
4. SE Nelson MN Gould JM Hampton 2005 A case-control study of the HER2 Ile655Val polymorphism in relation to risk of invasive breast cancer Breast Cancer Res 7 R357 R364
5. J Papewalis AYu Nikitin MF Rajewsky 1991 G to A polymorphism at amino acid codon 655 of the human erbB-2/HER2 gene Nucleic Acids Res 19 5452
6. D Xie XO Shu Z Deng 2000 Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk J Natl Cancer Inst 92 412 417
7. A Hishida N Hamajima H Iwata 2002 Re: Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk J Natl Cancer Inst 94 1807 1808
8. R Millikan A Eaton K Worley 2003 HER2 codon 655 polymorphism and risk of breast cancer in African Americans and Whites Breast Cancer Res Treat 79 355 364
9. C Keshava EC McCanlies N Keshava 2001 Distribution of HER2(V655) genotypes in breast cancer cases and controls in the United States Cancer Lett 173 37 41
10. SW Baxter IG Campbell 2001 Re: Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk J Natl Cancer Inst 93 557 559
11. S Wang-Gohrke J Chang-Claude 2001 Re: Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk J Natl Cancer Inst 93 1657 1659
12. KG Montgomery DM Gertig SW Baxter 2003 The HER2 I655V polymorphism and risk of breast cancer in women
13. E Akisik N Dalay 2004 Estrogen receptor codon 594 and HER2 codon 655 polymorphisms and breast cancer risk Exp Mol Pathol 76 260 263
14. D Pinto A Vasconcelos S Costa 2004 HER2 polymorphism and breast cancer risk in Portugal Eur J Cancer Prev 13 177 181
15. E Kamali-Sarvestani AR Talei A Merat 2004 Ile to Val polymorphism at codon 655 of HER-2 gene and breast cancer risk in Iranian women Cancer Lett 215 83 87
16. HJ An NK Kim D Oh 2005 Her2 genotype and breast cancer progression in Korean women Pathol Int 55 48 52
17. DG Cox SE Hankinson DJ Hunter 2005 The erbB2/HER2/neu receptor polymorphism Ile655Val and breast cancer risk Pharmacogenet Genomics 15 447 450
18. B Frank K Hemminki M Wirtenberger 2005 The rare ERBB2 variant Ile654Val is associated with an increased familial breast cancer risk Carcinogenesis 26 643 647
19. TG Kalemi AF Lambropoulos M Gueorguiev 2005 The association of p53 mutations and p53 codon 72, Her 2 codon 655 and MTHFR C677T polymorphisms with breast cancer in Northern Greece Cancer Lett 222 57 65
20. PR Benusiglio PD Pharoah PL Smith 2006 HapMap-based study of the 17q21 ERBB2 amplicon in susceptibility to breast cancer Br J Cancer 95 1689 1695
21. P Zúbor A Vojvodová J Danko 2006 HER-2 [Ile655Val] polymorphism in association with breast cancer risk: a population-based case-control study in Slovakia Neoplasma 53 49 55
22. E Papadopoulou K Simopoulos G Tripsianis 2007 Allelic imbalance of HER-2 codon 655 polymorphism among different religious/ethnic populations of northern Greece and its association with the development and the malignant phenotype of breast cancer Neoplasma 54 365 373
23. S Tommasi V Fedele R Lacalamita 2007 655Val and 1170Pro ERBB2 SNPs in familial breast cancer risk and BRCA1 alterations Cell Oncol 29 241 248
24. SC Lee MF Hou PC Hsieh 2008 A case-control study of the HER2 Ile655Val polymorphism and risk of breast cancer in Taiwan Clin Biochem 41 121 125
25. RC Millikan AJ Hummer MS Wolff 2005 HER2 codon 655 polymorphism and breast cancer: results from kin-cohort and case-control analyses Breast Cancer Res Treat 89 309 312
26. L Bax LM Yu N Ikeda 2006 Development and validation of MIX: comprehensive free software for meta-analysis of causal research data BMC Med Res Methodol 6 50
27. PR Benusiglio F Lesueur C Luccarini 2005 Common ERBB2 polymorphisms and risk of breast cancer in a white British population: a case-control study Breast Cancer Res 7 R204 R209
28. SJ Fleishman J Schlessinger N Ben-Tal 2002 A putative molecular-activation switch in the transmembrane domain of erbB2 Proc Natl Acad Sci U S A 99 15937 15940
29. K Takano K Ogasahara H Kaneda 1995 Contribution of hydrophobic residues to the stability of human lysozyme: calorimetric studies and X-ray structural analysis of the five isoleucine to valine mutants J Mol Biol 254 62 76
30. JL Rutter N Chatterjee S Wacholder 2003 The HER2 I655V polymorphism and breast cancer risk in Ashkenazim Epidemiology 14 694 700
31. MM Ameyaw M Tayeb N Thornton 2002 Ethnic variations in the HER-2 codon 655 genetic polymorphism previously associated with breast cancer J Hum Genet 47 172 175